The rising interest in GLP-1 agonists for metabolic conditions has sparked a debate about formats: transdermal systems versus pills . Typically, GLP-1 therapies were solely available in pill form, but https://alexiactcq501008.blogzag.com/84324059/glp-1-transdermal-delivery-systems-vs-pills-which-suitable-for-the-patient